New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - abacavir sulfate 23.4 mg/ml equivalent to 20 mg/ml abacavir base.;  ;   - oral solution - 20 mg/ml - active: abacavir sulfate 23.4 mg/ml equivalent to 20 mg/ml abacavir base.     excipient: banana flavour 59.256 ap0551 citric acid hydrochloric acid methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water saccharin sodium sodium citrate dihydrate sorbitol strawberry flavour 057883 ap0551 - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and children.